Systems Biology Investments Will Transform the Drug Development Process Within Five Years, Life Science Insights Reports

FRAMINGHAM, MA – OCTOBER 5, 2005 – Pharmaceutical and large biotechnology companies are actively investing in systems biology for both discovery and development, according to a recent study published by Life Science Insights, an IDC Company. Analysts contend that these investments will lead to direct improvements and increased efficiencies, potentially transforming the entire drug development process.

According to Alan Louie, research director at Life Science Insights, "Systems biology is beginning to play a prominent role in the drug development process. As systems biology approaches increasingly become an integral part of drug companies' research programs, both users and vendors need to recognize and respond to the evolving research and commercial landscape."

As drug development expands, systems biology companies are playing an increasing role in bringing together the biological knowledge available today. Systems biology companies will need to adopt an emerging technology approach to achieve long-term success. With technology maturation and market pressures, the commercial landscape will significantly change from what it is today, within five years.

Louie is the author of, The Commercial Systems Biology Landscape (Document #LSI1030), a new report examining the commercial vendor landscape in the emerging area of Systems Biology. In this report, Louie outlines all major product offerings in this area, describes a vision for what an ideal capability might look like, and delivers expectations for evolution of the systems biology space.

About Life Science Insights

Life Science Insights, an IDC Company, provides market research, analysis and consulting services to decision makers in life science markets. Clients include pharmaceutical and biotechnology companies, contract research organizations (CROs), government research organizations and technology vendors. Life Science Insights' team of specialist analysts and consultants provide intelligence and advice on technology trends, key market drivers, and end-user intentions. Life Science Insights is headquartered in Framingham, Mass. Visit for more information.